614 related articles for article (PubMed ID: 17318954)
1. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
2. [Predictive value of (99)Tc(m)-MIBI scintimammography in evaluation of the efficacy of neoadjuvant chemotherapy in patients with operable breast cancer].
Liu ZZ; Lu ZD; Zhang HW; Yang H; Liu H; Li LF; Li WL; Cui SD
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):544-6. PubMed ID: 22093636
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
Maini CL; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti ML; Vici P; Lopez M; Botti C
J Nucl Med; 1997 Oct; 38(10):1546-51. PubMed ID: 9379190
[TBL] [Abstract][Full Text] [Related]
4. Quantified 99mTc-MIBI scintigraphy for predicting chemotherapy response in breast cancer patients: factors that influence the level of 99m Tc-MIBI uptake.
Fuster D; Muñoz M; Pavia J; Palacín A; Bellet N; Mateos JJ; Martín F; Ortega M; Setoain FJ; Pons F
Nucl Med Commun; 2002 Jan; 23(1):31-8. PubMed ID: 11748435
[TBL] [Abstract][Full Text] [Related]
5. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between uptake of 99Tcm-MIBI and expression of multidrug resistant protein in breast cancer].
Zhang XM; Zhang ZW; Wu H
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):353-5. PubMed ID: 15312346
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
8. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
9. TC-99m MIBI SPECT imaging in patients with lung carcinoma: is it a functional probe of multidrug resistance genes?
Ak I; Gülbaş Z; Ocak S; Kaya E; Alataş F; Vardareli E; Metintaş M
J Comput Assist Tomogr; 2007; 31(5):795-9. PubMed ID: 17895794
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
11. The role of 99mTc-MIBI scintigraphy in the assessment of MDR1 overexpression in patients with musculoskeletal sarcomas: comparison with therapy response.
Burak Z; Ersoy O; Moretti JL; Erinç R; Ozcan Z; Dirlik A; Sabah D; Basdemir G
Eur J Nucl Med; 2001 Sep; 28(9):1341-50. PubMed ID: 11585293
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
Cui SD; Liu ZZ; Liu H; Li LF; Yang H; Li WL
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):606-8. PubMed ID: 16438870
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of (99m)Tc sestamibi scintigraphy in the evaluation of doxorubicin based chemotherapy response in patients with advanced breast cancer.
Alonso O; Delgado L; Núñez M; Vargas C; Lopera J; Andruskevicius P; Sabini G; Gaudiano J; Musé IM; Roca R
Nucl Med Commun; 2002 Aug; 23(8):765-71. PubMed ID: 12124482
[TBL] [Abstract][Full Text] [Related]
14. Prediction of chemotherapeutic response by Technetium 99m--MIBI scintigraphy in breast carcinoma patients.
Takamura Y; Miyoshi Y; Taguchi T; Noguchi S
Cancer; 2001 Jul; 92(2):232-9. PubMed ID: 11466674
[TBL] [Abstract][Full Text] [Related]
15. Different methods for the detection of small changes in uptake between single-photon emission computed tomography (SPECT) examinations: 99mTc-sestamibi in chemotherapy for breast tumours.
Jacobsson H; Wilczek B; Bergh J; von Schoultz E; Eriksson E; Larsson SA
Nucl Med Commun; 2006 Apr; 27(4):347-52. PubMed ID: 16531920
[TBL] [Abstract][Full Text] [Related]
16. Dynamic imaging: scintimammography.
Salvatore M; Del Vecchio S
Eur J Radiol; 1998 May; 27 Suppl 2():S259-64. PubMed ID: 9652532
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
18. 99mTc-MIBI SPET in non-small cell lung cancer in relationship with Pgp and prognosis.
Yüksel M; Cermik TF; Doğanay L; Karlikaya C; Cakir E; Salan A; Berkarda S
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):876-81. PubMed ID: 12111127
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance in multiple myeloma patients.
Fallahi B; Beiki D; Mousavi SA; Gholamrezanezhad A; Eftekhari M; Fard-Esfahani A; Alimoghaddam K; Mirpour S; Eskandarian A; Saghari M
Hell J Nucl Med; 2009; 12(3):255-9. PubMed ID: 19936339
[TBL] [Abstract][Full Text] [Related]
20. The role of Tc-99m sestamibi imaging in predicting clinical response to chemotherapy in lung cancer.
Dirlik A; Burak Z; Goksel T; Erinc R; Karakus H; Ozcan Z; Veral A; Ozhan M
Ann Nucl Med; 2002 Apr; 16(2):103-8. PubMed ID: 12043903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
